CAMP

THE SCIENCE AND TECHNOLOGY TO TRANSLATE ATMPs FROM LAB TO CLINIC

CAMP is a national competence centre in Vinnova’s research program for biological medicines. The centre focuses on the science and technology required to translate ATMPs from lab to clinic, including bioprocess development, GMP production and logistics. CAMP drives collaboration between researchers, GMP competent resources, industry and hospitals. CAMP gathers all of the university hospitals in Sweden, all research institutes with significant activity in ATMP and both large and small companies active in the ATMP field.

Coordinator: Umeå universitet

Partners: AcouSort, Akademiska sjukhuset, Amniotics, AstraZeneca, Bico Group, Celgene, Cellastra, Cytiva, Elicera Therapeutics, Göteborgs universitet, Karolinska Institutet, Karolinska Universitetssjukhuset, Key2Compliance, KTH, LIF, Linköpings universitet, Lunds universitet, MAGic Bioprocessing, Medicon Village, Miltenyi Biotec, MitoSense, NEOGAP Therapeutics, NextCell Pharma, Noricon, NorthX Biologics, Novartis, Region Örebro län, Region Skåne, Region Västerbotten, Region Östergötland, RISE, SVF Vaccines, Umeå universitet, Uppsala universitet, Västra Götalandsregionen, VERIGRAFT, VivaBioCell S.p.A., Xintela, XNK Therapeutics and Your Special Delivery Service.

WORK PACKAGES

Process Development
Infrastructure for GMP manufacturing
Quality control, shelf-life and logistics

For a list of projects see here

Contact: Jukka Lausmaa – Centre Director

Paul Kingham – Centre Coordinator

The overall long term objective is to develop general cell processing development principles and methods for an effective transfer from preclinical to clinical, GMP-compatible production.

CAMP

Related content